However, theres a downside: GLP-1s can lead to muscle loss, which may slow down metabolism and reduce some of their long-term health benefits
AMPK activation mitigates alpha-synuclein pathology and dopaminergic degeneration in cellular and mouse models of Parkinsons disease
Helps calm the immune system, particularly in conditions like IBS or inflammatory bowel disease (IBD)
Patients can reduce the likelihood of experiencing nausea by starting with a lower dose of the medication and gradually increasing the dose over time
Combining therapies that each exert significant effects on metabolic regulation, inflammation, and body composition creates a dynamic clinical picture that cannot be adequately managed through periodic symptom check-ins alone
Its stability-enhancing N-terminal modification allows for effective subcutaneous administration, and it is FDA-approved for HIV-related lipodystrophy.